Efficiency of a pneumatic device in controlling cuff pressure of polyurethane-cuffed tracheal tubes: a randomized controlled study

1471-2253-13-50 1471-2253 Research article Efficiency of a pneumatic device in controlling cuff pressure of polyurethane-cuffed tracheal tubes: a randomized controlled study JailletteEmmanuelleemmanuelle.jaillette@chru-lille.fr ZerimechFaridfarid.zerimech@chru-lille.fr De JonckheereJulienj.dejonckheere@hotmail.fr MakrisDemosthenesappollon7@hotmail.com BalduyckMalikamalika.balduyck@chru-lille.fr DurocherAlainalain.durocher@chru-lille.fr DuhamelAlainALAIN.DUHAMEL@UNIV-LILLE2.FR NseirSaads-nseir@chru-lille.fr

Critical Care Center, R. Salengro Hospital, University Hospital of Lille, Rue E. Laine, 59037 Lille cedex, France

Biochemistry and Molecular Biology Laboratory, Biochemistry Division, Pathology and Biology Center, University Hospital of Lille, 59037 Lille cedex, France

Clinical Investigation Center - Innovative Technologies, INSERM CIC-IT 807, University Hospital of Lille, 152 rue du Dr Alexandre Yersin, 59120 Loos, France

Intensive Care Unit, University Hospital of Larisa, University of Thessaly, Biopolis Street, 41110 Larisa, Greece

Biochemistry and Molecular Biology Laboratory, Faculty of Pharmacy, Lille II University, 1 place de Verdun, 59045 Lille, France

Medical Assessment Laboratory, EA 2694, Nord de France University, 1 place de Verdun, 59045 Lille, France

Epidemiology, Public Health and Quality of Care, Nord-de-France University, Lille, France

BMC Anesthesiology

Airway and respiratory management

1471-2253 2013 13 1 50 http://www.biomedcentral.com/1471-2253/13/50 10.1186/1471-2253-13-5024369057 31320131812201326122013 2013Jaillette et al.; licensee BioMed Central Ltd.This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Intubation Polyurethane Tracheal cuff Microaspiration Tracheal injury Pneumonia

Abstract

Background

The primary objective of this study was to determine the efficiency of a pneumatic device in controlling cuff pressure (P_cuff) in patients intubated with polyurethane-cuffed tracheal tubes. Secondary objectives were to determine the impact of continuous control of P_cuff, and cuff shape on microaspiration of gastric contents.

Methods

Prospective randomized controlled study. All patients requiring intubation and mechanical ventilation ≥48 h were eligible. The first 32 patients were intubated with tapered polyurethane-cuffed, and the 32 following patients were intubated with cylindrical polyurethane-cuffed tracheal tubes. Patients randomly received 24 h of continuous control of P_cuff using a pneumatic device (Nosten®), and 24 h of routine care of P_cuff using a manometer. Target P_cuff was 25 cmH₂O. P_cuff was continuously recorded, and pepsin was quantitatively measured in all tracheal aspirates during these periods.

Results

The pneumatic device was efficient in controlling P_cuff (med [IQ] 26 [24, 28] vs 22 [20, 28] cmH₂O, during continuous control of P_cuff and routine care, respectively; p = 0.017). In addition, percentage of patients with underinflation (31% vs 68%) or overinflation (53% vs 100%) of tracheal cuff, and percentage of time spent with underinflation (0.9 [0, 17] vs 14% [4, 30]) or overinflation (0 [0, 2] vs 32% [9, 54]) were significantly (p < 0.001) reduced during continuous control of P_cuff compared with routine care.

No significant difference was found in microaspiration of gastric content between continuous control of P_cuff compared with routine care, or between patients intubated with tapered compared with cylindrical polyurethane-cuffed tracheal tubes.

Conclusion

The pneumatic device was efficient in controlling P_cuff in critically ill patients intubated with polyurethane-cuffed tracheal tubes.

Trial registration

The Australian New Zealand Clinical Trials Registry (NCT01351259)

Background

Microaspiration of contaminated oropharyngeal secretions and gastric content frequently occurs in intubated critically ill patients, and plays a major role in the pathogenesis of ventilator-associated pneumonia (VAP) 1 . Aspiration of contaminated secretions is followed by tracheobronchial colonization that might progress into VAP depending on quantity, and virulence of microorganisms, and local and general defense mechanisms 2 .

During the last decade, significant progress has been achieved in the field of prevention of microaspiration, and VAP 3 4 . Polyurethane-cuffed tracheal tubes were reported to significantly reduce leakage in in vitro studies, and microaspiration in intubated critically ill patients 5 6 7 . In addition, three clinical studies reported significant reduction in VAP, and nosocomial pneumonia rate in patients intubated with polyurethane-cuffed tracheal tubes compared with those intubated with standard polyvinyl chloride-cuffed tracheal tubes 8 9 10 . However, limitations of these studies, including the use of subglottic aspiration in the intervention group in one study, clinical definition of nosocomial pneumonia, and before-after design should be taken into account. Recent data coming from in vitro studies also suggested a beneficial effect of tapered-shaped tracheal cuff in reducing microaspiration 11 12 13 .

Underinflation, and overinflation of tracheal cuff are major risk factors for microaspiration, VAP, and tracheal injury 14 15 16 . Despite routine control of cuff pressure (P_cuff) using a manometer, patients intubated with polyvinyl-chloride or polyurethane-cuffed tracheal tubes spend a large amount of time with underinflation and overinflation of tracheal cuff 6 17 . Continuous control of polyvinyl chloride-cuffed tracheal tubes using a pneumatic device was found to be associated with significantly reduced microaspiration of gastric content, and VAP incidence 18 . However, there are several differences between polyvinyl chloride and polyurethane, including thickness and physicochemical properties. Condensation formation in the pilot external balloon is very frequent in patients intubated with polyurethane-cuffed tracheal tubes. Whether condensation formation or other physicochemical properties of polyurethane could influence the efficiency of a pneumatic device in continuously controlling P_cuff is unknown. To our knowledge, no study has evaluated the efficiency of a pneumatic or an electronic device in continuously controlling P_cuff in patients intubated with polyurethane-cuffed tracheal tubes. Therefore, we conducted this randomized controlled trial to determine the efficiency of a pneumatic device in controlling P_cuff in critically-ill patients intubated with polyurethane-cuffed tracheal tube compared with routine care using a manual manometer. The secondary objectives were to determine the impact of continuous control of P_cuff, and cuff shape, i.e. tapered versus cylindrical, on microaspiration of gastric content.

Methods

The local institutional review board of the Lille University Hospital approved this study. The patients provided their written consent before randomization. In unconscious patients who were not able to give consent for inclusion in the study at randomization, relatives (next-of-kin) gave assent on every patient’s behalf, and patients were later given the opportunity to withdraw from the study. The study was registered at clinicaltrial.gov (NCT01351259).

Study design

This prospective randomized controlled cross-over study was conducted in a single 10-bed medical ICU during a 17-month period. Inclusion criteria were age >18 years, intubation in the ICU, and expected duration of invasive mechanical ventilation ≥48 hours. Exclusion criteria were enrolment in another trial, contraindication for semirecumbent position or for enteral nutrition, and intubation before ICU admission.

Primary objective was to determine the efficiency of a pneumatic device in controlling P_cuff in patients intubated with polyurethane-cuffed tracheal tubes compared with routine care using a manual manometer. Secondary objectives were to determine the impact of continuous control of P_cuff, and cuff shape, i.e. tapered versus cylindrical, on microaspiration of gastric contents.

All patients were intubated with polyurethane-cuffed tracheal tubes. Tracheal tube size was 7.5 and 8 in women and men, respectively. The first 32 patients were intubated with a tapered-cuffed tracheal tube (SealGuard®, Mallinckrodt, Athlone, Ireland), and the 32 following patients were intubated with a cylindrical-cuffed tracheal tube (Microcuff®, Kimberly-Clark, Georgia, USA). Patients were randomly assigned to receive continuous control of P_cuff for 24 hours followed by routine care for 24 hours, or routine care for 24 hours followed by continuous control P_cuff for 24 hours. The target P_cuff was 25 cm H₂O during the two 24-hour periods. A computer-generated random assignment list in balanced blocks of four was used. Sealed opaque individual envelopes containing treatment assignments were numbered sequentially. All caregivers were blinded to the randomization schedule and the block size. Because of the nature of the intervention, physicians and nurses could not be blinded to the randomization arm. However, engineer who performed the analysis of P_cuff recording (JD) and physicians who performed pepsin measurement (FZ, and MB) were blinded to study group assignment.

Tracheal cuff management

Routine care of tracheal cuff was managed according to an internal procedure adapted from the Société de Réanimation de Langue Française recommendations 19 . A manual manometer (Ambu® Cuff Pressure Gauge, Ambu A/S, Ballerup, Denmark) was used to check and adjust P_cuff every 8 hours. Continuous control of P_cuff was performed using a pneumatic device (Nosten®, Leved, St-Maur, France) 20 .

Outcome measurement

In all patients, P_cuff and airway pressure were continuously recorded (Physiotrace®, CHRU, Lille, France) at a digitizing frequency of 100 Hz during the 48 hours following randomization, including 24 hours of continuous control of P_cuff, and 24 hours of routine care. Nurses were blinded to recording data. Pepsin was quantitatively measured in all tracheal aspirates during the same two 24-hour periods. In order to avoid overlap in pepsin results between the two 24-hour periods, tracheal suctioning was always performed at the end of the first periods of P_cuff control. Tracheal aspirates were stored at -20°C. Quantitative pepsin measurement was performed by an ELISA technique 18 .

Study population

Measures aiming at preventing microaspiration were used in all patients including protocolized enteral nutrition, and sedation, minimal positive end expiratory pressure of 5 cm H₂O, and semirecumbent position. Continuous subglottic suctioning was not utilized. Nurses performed tracheal suctioning every 3 hours or more if clinically indicated, using an open tracheal suction system.

Definitions

The primary end point was the percentage of patients with underinflation (P_cuff <20 cm) H₂O or overinflation (P_cuff >30 cm H₂O) of tracheal cuff. Secondary outcomes included duration of underinflation and overinflation of P_cuff, coefficient of variation of P_cuff, and microaspiration of gastric content. P_cuff continuous recording data were used to determine the time spent with normal P_cuff, underinflation, and overinflation of tracheal cuff. The coefficient of variation of P_cuff was calculated as standard deviation/mean P_cuff × 100. Microaspiration of gastric content was defined by the presence of pepsin at significant level (>200 ng/mL) in at least one tracheal aspirate.

Statistical analyses

Based on the incidence of underinflation or overinflation of tracheal cuff in patients intubated with polyurethane-cuffed tracheal tubes and receiving routine care of P_cuff in our ICU (70%), we estimated an incidence of underinflation or overinflation in patients intubated with polyurethane-cuffed tracheal tubes and receiving continuous control of P_cuff of 30%. Randomly assigning 32 patients to two 24-hour periods of Pcuff control would allow detection of this difference with 80% power and a two-tailed significance level of 0.05. To determine the impact of cuff shape on microaspiration of gastric content, two groups of 32 patients intubated with tapered or cylindrical-cuffed tracheal tubes were required.

All P values were two-tailed. Categorical variables were described as frequencies (%). Because they were not normally distributed, continuous variables were described as median (interquartile range). McNemar’s test and Wilcoxon rank test were used to compare qualitative and quantitative variables between the two 24-hour periods, respectively. For comparisons between subgroups (tapered versus cylindrical-cuffed tracheal tubes), χ² test or Fisher exact test were used to compare qualitative variables, and Mann–Whitney U test was used to compare continuous variables.

To determine the impact of high airway pressures on the efficiency of the pneumatic device, we compared the time spent with underinflation and overinflation of P_cuff during continuous control of tracheal cuff between patients with high airway pressures (≥ 75^th quartile of airway pressures in the cohort), and those with lower airway pressures (<75^th quartile of airway pressures in the cohort).

Results

Patient characteristics

Sixty four patients were included in this study, including 32 intubated with tapered-cuffed tracheal tube, and 32 with cylindrical-cuffed tracheal tube. Study flow chart is presented in Figure 1. Median time from intubation to randomization was 3 days (1, 7). Median tracheal tube size was 8 mm (7.5-8). No significant difference was found in median time from intubation to randomization (4 1 8 vs 2 days 1 5 ), p = 0.470; or tracheal tube size (8 [7.5-8] vs 8 mm [7.5-8], p = 0.456) between patients intubated with tapered-cuffed tracheal tubes and those intubated with cylindrical-cuffed tracheal tubes, respectively. No significant difference was found in patient characteristics between the two periods of continuous control of P_cuff and routine care, or between patients intubated with tapered-cuffed tracheal tubes, and those intubated with cylindrical-cuffed tracheal tubes (Tables 1, and 2).

Figure 1

Study flowchart

Study flowchart. Pcuff, cuff pressure; P1, period 1; P2, period 2.

Table 1

Variables

All patients n = 64

Tapered cuff n = 32

Cylindrical cuff n = 32

Data are frequencies (%) or median (Interquartile range).

SAPS, simplified acute physiology score; LOD, logistic organ dysfunction; COPD, chronic obstructive pulmonary disease; ARDS, acute respiratory distress syndrome. Some patients had more than one cause for ICU admission.

*P values are for comparisons of tapered with cylindrical cuff.

Age

66 (55–75)

66 (58–77)

66 (54–72)

0.330

Male gender

43 (67)

20 (62)

23 (71)

0.594

SAPS II

45 (32–62)

45 (29–62)

42 (37–62)

0.289

LOD score

6 (3–9)

6 (2–10)

6 (4–9)

0.818

Comorbidities

Diabetes mellitus

16 (25)

10 (31)

6 (18)

0.386

COPD

23 (35)

11 (34)

12 (37)

>0.999

Cardiovascular disease

12 (18)

7 (21)

5 (15)

0.749

Cirrhosis

1 (1)

1 (3)

>0.999

Causes for ICU admission

Acute exacerbation of COPD

18 (28)

10 (31)

8 (25)

0.781

ARDS

7 (10)

3 (9)

4 (12)

>0.999

Septic shock

15 (23)

10 (31)

5 (15)

0.238

Community-acquired pneumonia

19 (29)

8 (25)

11 (34)

0.584

Hospital acquired pneumonia

24 (37)

16 (50)

8 (25)

0.071

Congestive heart failure

4 (6)

2 (6)

>0.999

Neurologic failure

7 (10)

2 (6)

5 (15)

0.426

Poisoning

3 (4)

2 (6)

1 (3)

>0.999

Soft tissue infetion

2 (3)

2 (6)

0,492

Table 2

Variables

Continuous control of P _cuffn = 64

Routine care n = 64

Continuous control of P _cuffn = 64

Routine care n = 64

Tapered cuff n = 32

Cylindrical cuff n = 32

Tapered cuff n = 32

Cylindrical cuff n = 32

Data are frequencies (%) or median (Interquartile range).

P_cuff, cuff pressure; PEEP, positive end-expiratory pressure; ACV, assist-control ventilation; PSV, pressure support ventilation; BPPV, bilevel positive pressure ventilation.

Quantity of enteral nutrition, ml/day

1000

0.433

1000

0.960

1000

0.241

(500–1000)

(500–1500)

(500–1000)

(500–1500)

Gastric residual volume, ml

0 (0–20)

0.871

0 (0–15)

0 (0–27)

0.726

0 (0–60)

0 (0–5)

0.294

Sedation

28 (43)

29 (45)

> 0.999

14 (43)

>0.999

15 (46)

14 (43)

>0.999

Ramsay score

2 (2–3)

0.641

2 (2–3)

0.718

2 (2–3)

0.729

Neuromuscular blocking agent use

6 (9)

7 (10)

> 0.999

3 (9)

>0.999

3 (9)

4 (12)

>0.999

Glasgow coma score

14 (10–15)

15 (10–15)

0.310

13 (10–15)

14 (8–15)

0.738

14 (10–15)

15 (8–15)

0.908

PEEP

6 (5–8)

6 (5–9)

0.943

6 (5–8)

7 (5–9)

0.234

6 (5–9)

7 (5–9)

0.166

Ventilatory mode

0.329

0.885

0.433

ACV

36 (56)

37 (57)

18 (56)

21 (65)

16 (50)

PSV

23 (35)

25 (39)

11 (34)

12 (37)

10 (31)

15 (46)

BPPV

5 (7)

2 (3)

3 (9)

2 (6)

1 (3)

Stress ulcer prophylaxis or treatment

>0.999

0.688

0.109

Sucralfate

32 (50)

15 (46)

17 (53)

13 (40)

19 (59)

Proton pump inhibitors

25 (39)

13 (40)

12 (37)

13 (40)

12 (37)

Prokinetic drugs

12 (18)

> 0.999

6 (18)

>0.999

7 (21)

5 (15)

0.749

Vomiting

3 (4)

1 (1)

0.625

3 (9)

0.237

1 (3)

>0.999

Head-of-bed position

40 (35–40)

0.846

40 (35–45)

40 (35–40)

0.602

40 (35–40)

40 (35–45)

0.244

Continuous control versus routine care of tracheal cuff

The pneumatic device was efficient in controlling P_cuff. Percentage of patients with underinflation or overinflation of tracheal cuff, coefficient of variation of P_cuff, and percentage of time spent with underinflation and overinflation of tracheal cuff were significantly lower during continuous control of P_cuff compared with routine care. P_cuff, and percentage of time spent with P_cuff 20–30 cmH₂O were significantly higher during continuous control of P_cuff compared with routine control. No significant difference was found in rate of microaspiration of gastric content, mean pepsin level, or percentage of tracheal aspirates positive for pepsin between continuous control of P_cuff and routine care (Table 3). No significant interaction was found between continuous control of P_cuff and cuff shape (p = 0.93).

Table 3

Variables

Continuous control of P _cuffn = 64

Routine care n = 64

OR (95% CI)

Data are frequencies (%) or median (Interquartile range). P_cuff, cuff pressure.

Yes indicates that a patient had the variable at least once.

Recording duration, h

24 (23–24)

0.198

Mean airway pressure, cm H₂O

13 (11–18)

13 (11–17)

0.216

Mean P_cuff, cm H₂O

26 (24–28)

22 (20–28)

0.017

Coefficient of P_cuff variation, %

5 (3–12)

19 (15–30)

<0.001

P_cuff 20-30 cm H₂O

yes

64 (100)

% of recording time

95 (70–99)

44 (30–59)

<0.001

P_cuff <20 or >30, cm H₂O

Yes

41 (66)

64 (100)

<0.001

Duration >30 min

33 (51)

64 (100)

<0.001

P_cuff <20, cm H₂O

Yes

19 (29)

60 (93)

<0.001

1.46 (1.23-1.73)

Duration > 30 min

16 (25)

57 (89)

<0.001

2.63 (1.11-6.21)

% of recording time

0.01 (0–2)

32 (9–54)

<0.001

P_cuff >30, cm H₂O

Yes

33 (51)

62 (96)

0.001

1.57 (1.10-2.24)

Duration >30 min

25 (39)

54 (84)

<0.001

1.50 (1.11-2.20

% of recording time

0.9 (0–17)

14 (4–30)

<0.001

Microaspiration of gastric content

32 (50)

38 (59)

0.238

Pepsin, ng/mL

185 (113–296)

203 (120–338)

0.171

% of tracheal aspirates positive for pepsin

29 (0–74)

45 (0–100)

0.162

Tapered versus cylindrical cuff shape during continuous control of P_cuff

During continuous control of P_cuff, percentage of patients with underinflation of tracheal cuff >30 minutes was significantly lower in patients intubated with tapered-cuffed tracheal tubes compared with those intubated with cylindrical-cuffed tracheal tubes. No significant difference was found in terms of P_cuff, percentage of patients with underinflation or overinflation, coefficient of variation of P_cuff, and percentage of time spent with underinflation or overinflation between the two groups during the same period (Table 4).

Table 4

Variables

Continuous control of P _cuffn = 64

Routine care n = 64

Tapered cuff n = 32

Cylindrical cuff n = 32

Tapered cuff n = 32

Cylindrical cuff n = 32

Data are frequencies (%) or median (Interquartile range).

P_cuff, cuff pressure. Yes indicates that a patient had the variable at least once.

*OR (95% CI) 3.20 (1.12-9.12).

Recording duration, h

24 (23–24)

24 (23–25)

0.662

24 (23–25)

24 (23–24)

0.229

Mean airway pressure, cm H₂O

13 (10–18)

13 (11–16)

0.749

12 (10–20)

15 (11–15)

0.214

Mean P_cuff, cm H₂O

26 (25–28)

25 (23–28)

0.844

21 (19–26)

24 (21–30)

0.143

Coefficient of P_cuff variation, %

5 (3–9)

6 (3–15)

0.382

18 (15–30)

20 (14–39)

0.789

P_cuff 20-30 cm H₂O

yes

32 (100)

% of recording time

97 (82–99)

88 (56–99)

0.147

42 (30–62)

44 (29–57)

0.811

P_cuff <20 or >30 cm H₂O

Yes

19 (59)

22 (68)

0.856

32 (100)

>0.999

Duration >30 min

14 (43)

19 (59)

0.455

30 (93)

32 (100)

>0.999

P_cuff <20 cm H₂O

Yes

6 (18)

13 (40)

0.116

29 (90)

31 (96)

>0.999

Duration > 30 min

3 (9)

13 (40)

0.011*

29 (90)

28 (87)

0.371

% of recording time

0 (0–0)

0 (0–12)

0.549

41 (17–62)

21 (8–47)

0.049

P_cuff >30 cm H₂O

Yes

15 (46)

18 (56)

0.903

31 (96)

>0.999

Duration >30 min

12 (37)

13 (40)

>0.999

24 (75)

30 (93)

0.235

% of recording time

0.6 (0–24)

1.4 (0–48)

0.652

11 (2–17)

20 (6–18)

0.031

Microaspiration of gastric content

13 (40)

19 (59)

0.211

18 (56)

20 (62)

0.799

Pepsin, ng/mL

154 (105–230)

214 (126–466)

0.066

175 (121–252)

238 (101–664)

0.238

% of tracheal aspirates positive for pepsin

0 (0–57)

43 (0–100)

0.073

40 (0–86)

50 (0–100)

0.310

Tapered versus cylindrical cuff shape during routine care of P_cuff

During routine care, percentage of time spent with underinflation of tracheal cuff was significantly higher, and percentage of time spent with overinflation of tracheal cuff was significantly lower in patients intubated with tapered-cuffed tracheal tubes compared with those intubated with cylindrical-cuffed tracheal tubes. No significant difference was found in coefficient of variation of P_cuff, or percentage of patients with underinflation or overinflation of tracheal cuff between the two groups during the same period (Table 4).

Impact of cuff shape on microaspiration

No significant difference was found in microaspiration of gastric content rate, mean pepsin level or percentage of tracheal aspirates positive for pepsin between patients intubated with tapered-cuffed tracheal tubes and those intubated with cylindrical-cuffed tracheal tubes during continuous control of P_cuff or routine care (Table 4).

Other results

During continuous control of P_cuff, important condensation was observed in the pilot balloon in 7 (22%) patients intubated with tapered-cuffed tracheal tube compared with 10 (31%) patients intubated with cylindrical-cuffed tracheal tube (p = 0.571).

No significant difference was found in percentage of time spent with underinflation (median [IQR] 0.07% [0.0004-16] versus 0.01% [0.0003-0.6], p = 0.359), or overinflation of tracheal cuff (6% [0.27-37] versus 0.34% [0.02-11]) between patients with high airway pressures (n = 16) and those with lower airway pressures (n = 48), respectively.

Discussion

The percentage of patients with underinflation or overinflation of tracheal cuff, percentage of time spent with underinflation or overinflation of tracheal cuff, and coefficient of variation of P_cuff were significantly lower during continuous control of P_cuff compared with routine care. Further, percentage of time spent with P_cuff 20–30 cmH₂O, and mean P_cuff were significantly higher during continuous control of P_cuff compared with routine care. However, no significant difference was found in the incidence of microaspiration of gastric content between continuous control of P_cuff compared with routine care or between patients intubated with tapered-cuffed tracheal tubes and those intubated with cylindrical-cuffed tracheal tubes.

To our knowledge, our study is the first to demonstrate the efficiency of the pneumatic device in controlling P_cuff in critically-ill patients intubated with polyurethane-cuffed tracheal tubes. Previous studies found similar results in animals and humans intubated with polyvinyl chloride-cuffed tracheal tubes 20 21 . The percentage of patients with underinflation of tracheal cuff >30 minutes during continuous control of P_cuff was relatively high (25%). This could be explained by the physicochemical characteristics of polyurethane, namely its hydrophilic aspect, resulting in condensation formation especially during continuous control of P_cuff. In our study, small condensation formation was rarely observed in the pilot balloon during routine care of P_cuff. However, important condensation formation filling the whole pilot balloon was frequently observed during continuous control of P_cuff. The fact that evaporation is probably reduced in closed circuit during continuous control of P_cuff might explain this difference in condensation formation between routine care and continuous control of P_cuff. Further studies directly comparing efficiency of the pneumatic device in polyurethane and polyvinyl chloride-cuffed tracheal tubes are needed to confirm our results. Although previous studies have demonstrated the efficiency of the pneumatic device in controlling P_cuff in patients intubated with PVC-cuffed tracheal tubes, the current study allow the generalization of this observation to patients intubated with polyurethane-cuffed tracheal tubes. Given the growing evidence supporting the use of polyurethane-cuffed tracheal tubes to prevent microaspiration and VAP, our results are necessary before performing further studies aiming to evaluate the combined beneficial effects of using polyurethane-cuffed tracheal tubes and continuous control of P_cuff in preventing VAP.

In spite of efficient control of P_cuff, no significant difference was found in microaspiration of gastric content between continuous control of P_cuff and routine care. One potential explanation for this result is the optimal routine care provided during the study, and the use of polyurethane-cuffed tracheal tubes. These tubes have been demonstrated to significantly reduce microaspiration in critically ill patients 5 6 . Further, our study is probably underpowered to detect such an effect, since microaspiration of gastric content was a secondary outcome and the number of included patients was calculated based on the primary outcome. Further studies are needed to determine the impact of continuous control of P_cuff on the incidence of microaspiration, and VAP. However, whilst our study was underpowered to detect a difference in microaspiration, it was correctly powered to draw a valuable conclusion on primary outcome, i.e. the efficiency of the pneumatic device in controlling P_cuff. In fact, the number of patients required to detect the estimated difference in percentage of patients with underinflation or overinflation of P_cuff, with an alpha risk of 5% and a power of 80%, was 32 per group. As 32 patients were included in each study group, our study is sufficiently powered to conclude that the pneumatic device is efficient in controlling P_cuff. This result would allow future studies to evaluate the impact of the pneumatic device on the prevention of complications related to underinflation and overinflation of P_cuff. Although our previous study has already suggested beneficial effects of continuous control of P_cuff in reducing microaspiration and VAP 18 , it was conducted in patients intubated with PVC-cuffed tracheal tubes. Therefore, these results could not be generalized to patients intubated with polyurethane-cuffed tracheal tubes. Further studies with larger sample size are required in these patients to determine the impact of continuous control of P_cuff on prevention of cuff-related complications such as microaspiration, and VAP.

Some significant differences, including percentage of time with underinflation and overinflation were found between patients intubated with tapered-cuffed tracheal tubes compared with those intubated with cylindrical-cuffed tracheal tubes. These differences could be explained by different cuff shape between the two groups. No significant effect was found of tracheal cuff shape on microaspiration of gastric content. However, during continuous control of P_cuff a trend towards lower pepsin level and percentage of tracheal aspirates positive for pepsin was found in patients intubated with tapered-cuffed tracheal tubes compared with those intubated with cylindrical-cuffed tracheal tubes. Further, in spite of significantly higher percentage of time spent with underinflation of tracheal cuff in patients intubated with tapered-cuffed tracheal tubes compared with those intubated with cylindrical-cuffed tracheal tubes during routine care, microaspiration of gastric content rate was similar in the two groups. This result also suggests better sealing with tapered compared with cylindrical tracheal cuffs. However, our study was probably underpowered to detect a significant difference in microaspiration rate between the two groups.

Two recent in vitro studies found tapered-shaped tube cuff to considerably improve sealing characteristics of polyvinyl chloride tube cuffs 11 13 . However, no significant effect of the tapered-shaped cuff was found in polyurethane tube cuffs. In contrast, another in vitro study reported that tapered polyurethane cuff was more efficient than cylindrical polyurethane cuff in larger tracheal diameter in preventing fluid leakage 12 . Different study design might explain these conflicting results. In a prospective observational before-after study, our group found no significant difference in microaspiration of gastric content between patients intubated with tapered polyurethane-cuffed tracheal tubes compared with those intubated with cylindrical polyurethane-cuffed tracheal tubes 6 . Further clinical studies are required to determine the impact of tracheal cuff shape on the incidence of microaspiration, and VAP.

No significant difference was found in airway pressures between patients intubated with tapered compared with those intubated with cylindrical tracheal cuffs. Previous studies demonstrated that P_cuff was tightly correlated to airway pressure 22 23 . The relatively low airway pressures found in study patients were similar as those previously reported in other ICU patients 6 24 25 . This might strengthen our findings, since these results could be generalized to patients with similar airway pressure. Percentage of time spent with underinflation, and overinflation of P_cuff during continuous control of P_cuff was not significantly different between patients with high airway pressures and those with lower airway pressures, suggesting that the pneumatic device is efficient in patients with high airway pressures, such as those with severe asthma or ARDS. However, no definite conclusion could be drawn in this subgroup because of the small number of patients (n = 16).

Our study has some limitations. First, this study was performed in a single ICU. Therefore, our results could not be generalized to other ICU patients. Second, our study did not evaluate the impact of continuous control of P_cuff on outcomes such as VAP or tracheal injury. However, in order to adjust for patient-related confounders, such as tracheal size and aspect, airway pressures, and tracheal tube size, continuous control and routine care of P_cuff were performed in the same patient. Therefore, it was not possible to evaluate these outcomes. Further, it was mandatory to evaluate the efficiency of the device in controlling P_cuff before performing studies on its impact on prevention of complications. Finally, randomization for tracheal cuff shape was performed per period and not per patient. However, intubation is often an urgent procedure. Therefore, it is very difficult to perform randomization per patient in such a study. In addition, the impact of cuff shape on microaspiration was a secondary outcome.

Conclusion

We conclude that the pneumatic device is efficient in controlling P_cuff in critically ill patients intubated with polyurethane-cuffed tracheal tube. Further studies are needed to determine the impact of continuous control of P_cuff and tracheal cuff shape on microaspiration, VAP, and tracheal injury.

Key messages

• The pneumatic device is efficient in controlling P_cuff in critically ill patients intubated with polyurethane-cuffed tracheal tube.

• Conical cuff shape could be beneficial in preventing microaspiration in critically ill patients.

• Further studies are needed to determine the impact of continuous control of P_cuff and tracheal cuff shape on microaspiration, and VAP in patients intubated with polyurethane-cuffed tracheal tubes.

Abbreviations

ICU: Intensive care unit; Pcuff: Cuff pressure; VAP: Ventilator-associated pneumonia.

Competing interests

SN: Covidien (advisory board), other authors: none.

Authors’ contribution

EJ, ADur, and SN designed this study. EJ, FZ, JD, MB, and SN collected the data. ADuh performed statistical analyses. EJ, and SN wrote the manuscript, and all authors participated in its critical revision. EJ, and SN had full access to all data in the study and had final responsibility for the decision to submit for publication. All authors read and approved the final manuscript.

Acknowledgements

The authors would like to thank Mrs. Catherine Lelorne, Mrs. Véronique Lemaire and Mrs. Nadine Parsy for their skilful assistance in pepsin measurement.

Financial support

Covidien and Kimberly-Clark donated tracheal tubes used in this study. None of these companies had any role in the design, study conduct, data analyses or reporting.

Microaspiration in intubated critically ill patients: diagnosis and preventionNseirSZerimechFJailletteEArtruFBalduyckMInfect Disor Drug Target20111141342310.2174/187152611796504827Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomesCravenDEChroneouAZiasNHjalmarsonKIChest200913552152810.1378/chest.08-161718812452Ventilator-associated pneumonia and its preventionBouadmaLWolffMLucetJ-CCurr Opin Infect Dis20122539540410.1097/QCO.0b013e328355a83522744316Novel preventive strategies for ventilator-associated pneumoniaCoppadoroABittnerEBerraLCrit Care20121621010.1186/cc11225368135622429668Effect of positive expiratory pressure and type of tracheal cuff on the incidence of aspiration in mechanically ventilated patients in an intensive care unitLucangeloUZinWAAntonagliaVPetrucciLVivianiMBuscemaGBorelliMBerlotGCrit Care Med20083640941310.1097/01.CCM.0000297888.82492.3118007268Impact of polyurethane on variations in tracheal cuff pressure in critically ill patients: a prospective observational studyNseirSZerimechFDe JonckheereJAlvesIBalduyckMDurocherAIntensive Care Med2010361156116310.1007/s00134-010-1892-720397001Fluid leakage past tracheal tube cuffs: evaluation of the new Microcuff endotracheal tubeDullenkopfAGerberAWeissMIntensive Care Med2003291849185310.1007/s00134-003-1933-612923620Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumoniaLorenteLLecuonaMJiménezAMoraMLSierraAAm J Respir Crit Care Med20071761079108310.1164/rccm.200705-761OC17872488Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: a pilot studyPoelaertJDepuydtPDe WolfAVan de VeldeSHerckIBlotSJ Thor Cardiovascular Surg200813577177610.1016/j.jtcvs.2007.08.052A polyurethane cuffed endotracheal tube is associated with decreased rates of ventilator-associated pneumoniaMillerMAArndtJLKonkleMAChenowethCEIwashynaTJFlahertyKRHyzyRCJ Crit Care20112628028610.1016/j.jcrc.2010.05.03520655698Comparison of air-sealing characteristics of tapered- vs. cylindrical-shaped high-volume, low-pressure tube cuffsMadjdpourCMauchJDaveMHSpielmannNWeissMActa Anaesthesiol Scand20125623023510.1111/j.1399-6576.2011.02542.x22091784Effect of tracheal tube cuff shape on fluid leakage across the cuff: an in vitro studyDaveMHFrotzlerASpielmannNMadjdpourCWeissMBrit J Anaesthesia201010553854310.1093/bja/aeq202Fluid leakage across tracheal tube cuff, effect of different cuff material, shape, and positive expiratory pressure: a bench-top studyZanellaAScaravilliVIsgròSMilanMCressoniMPatronitiNFumagalliRPesentiAIntensive Care Med20113734334710.1007/s00134-010-2106-z21152894Leakage of fluid past the tracheal tube cuff in a benchtop modelYoungPJRollinsonMDownwardGHendersonSBrit J Anaesthesia19977855756210.1093/bja/78.5.557Pneumonia in intubated patients: role of respiratory airway careRelloJSoñoraRJubertPArtigasARuéMVallésJAm J Respir Crit Care Med199615411111510.1164/ajrccm.154.1.86806658680665Endotracheal cuff pressure and tracheal mucosal blood flow: endoscopic study of effects of four large volume cuffsSeegobinRDvan HasseltGLBrit Med J198428896596810.1136/bmj.288.6422.965Variations in endotracheal cuff pressure in intubated critically ill patients: prevalence and risk factorsNseirSBrissonHMarquetteC-HChaudPDi PompeoCDiarraMDurocherAEur J Anaesthsiol20092622923410.1097/EJA.0b013e3283222b6eContinuous control of tracheal cuff pressure and microaspiration of gastric contents in critically ill patientsNseirSZerimechFFournierCLubretRRamonPDurocherABalduyckMAm J Respir Crit Care Med20111841041104710.1164/rccm.201104-0630OC21836137Quel abord trachéal pour la ventilation mécanique des malades de réanimation? (à l’exclusion du nouveau né)ChastreJBedockBClairBGehannoPLacazeTLesieurOPicart-JacqJYPlaisancePRavussinPSamainEReanimation19987438442Control of tracheal cuff pressure: a pilot study using a pneumatic deviceDuguetAD’AmicoLBiondiGProdanovicHGonzalez-BermejoJSimilowskiTIntensive Care Med20073312813210.1007/s00134-006-0417-x17063357Continuous control of endotracheal cuff pressure and tracheal wall damage: a randomized controlled animal studyNseirSDuguetACopinM-CDe JonckheereJZhangMSimilowskiTMarquetteC-HCrit Care200711R10910.1186/cc6142255676117915017Influence of airway pressure on minimum occlusive endotracheal tube cuff pressureGuytonDCBarlowMRBesselievreTRCrit Care Med199725919410.1097/00003246-199701000-000188989182Laboratory evaluation of 4 brands of endotracheal tube cuff inflatorBlanchPBRespir Care20044916617314744266Mean airway pressure as an index of mean alveolar pressureValtaPCorbeilCChasséMBraidyJMilic-EmiliJAm J Respir Crit Care Med19961531825183010.1164/ajrccm.153.6.86650418665041Evaluation of an intervention to maintain endotracheal tube cuff pressure within therapeutic rangeSoleMLSuXTalbertSPenoyerDAKalitaSJimenezELudyJEBennettMAm J Crit Care20112010911710.4037/ajcc2011661350617421362715

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2253/13/50/prepub